...
首页> 外文期刊>Molecular pain >Rat NaV1.7 loss-of-function genetic model: Deficient nociceptive and neuropathic pain behavior with retained olfactory function and intra-epidermal nerve fibers
【24h】

Rat NaV1.7 loss-of-function genetic model: Deficient nociceptive and neuropathic pain behavior with retained olfactory function and intra-epidermal nerve fibers

机译:RAT NAV1.7函数丧失遗传模型:保留嗅觉功能和表皮内神经纤维的缺乏伤害性和神经性疼痛行为

获取原文

摘要

Recapitulating human disease pathophysiology using genetic animal models is a powerful approach to enable mechanistic understanding of genotype-phenotype relationships for drug development. NaV1.7 is a sodium channel expressed in the peripheral nervous system with strong human genetic validation as a pain target. Efforts to identify novel analgesics that are non-addictive, resulted in industry exploration of a class of sulfonamide compounds that bind to the fourth voltage-sensor domain of NaV1.7. Due to sequence differences in this region, sulfonamide blockers generally are potent on human but not rat NaV1.7 channels. To test sulfonamide-based chemical matter in rat models of pain, we generated a humanized NaV1.7 rat expressing a chimeric NaV1.7 protein containing the sulfonamide-binding site of the human gene sequence as a replacement for the equivalent rat sequence. Unexpectedly, upon transcription the human insert was spliced out, resulting in a premature stop codon. Using a validated antibody, NaV1.7 protein was confirmed to be lost in the brainstem, dorsal root ganglia (DRG), sciatic nerve and gastrointestinal tissue but not in nasal turbinates or olfactory bulb in rats homozygous for the knock-in allele (HOM-KI). HOM-KI rats exhibited normal intraepidermal nerve fiber density with reduced tetrodotoxin-sensitive current density and action potential firing in small diameter DRG neurons. HOM-KI rats did not exhibit nociceptive pain responses in hot plate or capsaicin-induced flinching assays and did not exhibit neuropathic pain responses following spinal nerve ligation. Consistent with expression of chimeric NaV1.7 in olfactory tissue, HOM-KI rats retained olfactory function. This new genetic model highlights the necessity of NaV1.7 for pain behavior in rats and indicates that sufficient inhibition of NaV1.7 in humans may reduce pain in neuropathic conditions. Due to preserved olfactory function, this rat model represents an alternative to global NaV1.7 knockout mice that require time-intensive hand feeding during early postnatal development.
机译:使用遗传动物模型重新承载人类疾病病理生理学是一种强大的方法,可以实现对药物发育的基因型 - 表型关系的机械理解。 Nav1.7是在外周神经系统中表达的钠通道,具有强烈的人类遗传验证作为止痛目标。努力识别非上瘾的新型镇痛药,导致行业探索一类与NAV1.7的第四电压传感器结构域结合的磺酰胺化合物。由于该区域的序列差异,磺酰胺封闭剂通常在人类而不是大鼠NAV1.7通道上有效。为了在大鼠疼痛模型中测试基于磺酰胺的化学物质,我们产生了表达含有人基因序列的磺酰胺结合位点的嵌合Nav1.7蛋白的人源化Nav1.7大鼠作为等效大鼠序列的替代品。出乎意料地,在转录时,人插入物被拼接出来,导致过早的终止密码子。使用经过验证的抗体,Nav1.7蛋白被证实在脑干中丢失,背根神经节(DRG),坐骨神经和胃肠组织,但在纯合的爆击等位基因大鼠中,不在鼻腔鼻甲或嗅灯泡中(HOM- ki)。 HOM-KI大鼠表现出正常的胸腔内神经纤维密度,具有降低的四抗毒素敏感电流密度和小直径DRG神经元的动作电位烧制。 HOM-KI大鼠在热板或辣椒素诱导的脱落测定中没有表现出伤害性疼痛反应,并且在脊髓神经连接后没有表现出神经性疼痛反应。与嵌入式组织中的嵌合Nav1.7的表达一致,HOM-Ki大鼠保留了嗅觉功能。这种新的遗传模型突出了NAV1.7在大鼠疼痛行为的必要性,表明人类中的NAV1.7的充分抑制可能会降低神经病病症的疼痛。由于保留了嗅觉功能,该大鼠模型代表了全球NAV1.7敲除小鼠的替代方案,该小鼠需要在早期出生后的早期发育中的时间密集喂养。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号